Healthcare Realty Trust (HR) has given investors fresh numbers to consider after a record first quarter, raising full-year FFO and same-store NOI guidance on strong leasing, higher occupancy, solid tenant retention, and active capital moves.

The recent earnings beat, higher full year guidance, fresh joint venture activity, and a new delayed draw term loan have coincided with a firming share price. A 30 day share price return of 10.63% and a 1 year total shareholder return of 34.56% suggest momentum has picked up after weaker longer term performance, including a 5 year total shareholder return of negative 17.56%.

If this kind of rebound has your attention, it could be a good moment to see what else is moving in healthcare real estate and related themes using solid balance sheet and fundamentals stocks screener (44 results)

With the shares roughly in line with the average analyst price target yet trading at what some models flag as a sizable intrinsic discount, the key question is whether HR still offers upside or if the market is already pricing in future growth.

Most Popular Narrative: 0% Overvalued

With Healthcare Realty Trust last closing at $19.25 against a narrative fair value of about $19.18, the current price sits almost exactly on that estimate while the share price trend hints at growing investor interest.

Balance sheet strengthening via significant asset dispositions (focused on non-core, low-growth properties), targeted deleveraging, and a right-sized dividend increases financial flexibility for reinvestment, positioning the company for improved net margins, earnings quality, and greater capital deployment into high-return projects.

Want to see what underpins that near match between price and fair value? The narrative leans on moderate revenue growth, slimmer losses, and a very punchy future earnings multiple. The full breakdown shows how those moving parts fit together.

Result: Fair Value of $19.18 (ABOUT RIGHT)

However, there are clear fault lines in this story, including execution risks around the operational overhaul and the possibility that high leverage and refinancing needs constrain future flexibility.

Another Lens: DCF Flags a Very Different Story

While the narrative fair value sits close to the current $19.25 share price, the SWS DCF model points in a very different direction, with an estimate of $29.76, or about 35% above where the stock trades today. Which version of value do you think is closer to reality?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Healthcare Realty Trust for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The mix of optimism and concern around Healthcare Realty Trust is clear, so act quickly, review the data, and decide where you stand by checking the 1 key reward and 2 important warning signs

Looking for more investment ideas?

HR might be front of mind today, but you do not want to stop there. Broaden your watchlist and give yourself more options with a few focused screens.

• Tap into potential value by scanning companies that combine quality fundamentals with attractive pricing using 51 high quality undervalued stocks.
• Strengthen your income approach by pinpointing companies with resilient payout profiles through 13 dividend fortresses.
• Cut through the noise and concentrate on financially resilient names by filtering with 70 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.